English   español  

Browsing by Author Zaldívar-Díez, Josefa

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
RightsPreviewIssue DateTitleAuthor(s)Type
openAccessE. de la Rosa_abstract-pag.5 .pdf.jpgMay-2016A GSK-3b modulator delays photoreceptor cell death and preserves visual function in the rd10 mouse model of retinitis pigmentosaHernández-Sánchez, Catalina  ; Villarejo-Zori, Beatriz ; Zaldívar-Díez, Josefa; Marchena, Miguel; Gil, Carmen  ; Villa, Pedro de la; Martínez, Ana  ; De la Rosa, Enrique J.  comunicación de congreso
openAccessacs.jmedchem_zaldívar-díez_2019.pdf.jpg11-Dec-2019Benzothiazole-based LRRK2 inhibitors as Wnt enhancers and promoters of oligodendrocytic fateZaldívar-Díez, Josefa; Li, Lingling; García, Ana M. ; Zhao, Wenning; Medina-Menendez, Cristina; Haggarty, Stephen J.; Gil, Carmen  ; Morales, Aixa V. ; Martínez, Ana  artículo
openAccessCognitive_Isabel_Preprint_2020.pdf.jpgDec-2020Cognitive enhancement, TAU phosphorylation reduction, and neuronal protection by the treatment of an LRRK2 inhibitor in a tauopathy mouse modelCastro-Sánchez, Sara; Zaldívar-Díez, Josefa; Luengo, Enrique; López, Manuela G.; Gil, Carmen  ; Martínez, Ana  ; Lastres-Becker,Isabelartículo
openAccessFuture Med Chem_Sebastián-Pérez_2019.pdf.jpg2-Aug-2019Discovery of novel Schistosoma mansoni PDE4A inhibitors as potential agents against schistosomiasisSebastián-Pérez, Víctor; Schroeder, Susanne; Munday, Jane C.; van der Meer, Tiffany; Zaldívar-Díez, Josefa; Siderius, Marco; Koning, Harry de; Martínez, Ana  ; Campillo, Nuria E.  ; Leurs, Rob; Gil, Carmen  artículo
openAccessEuropean J. Medicinal Chemistry 2017.pdf.jpg29-Sep-2017Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agentsSalado, Irene G. ; Zaldívar-Díez, Josefa; Sebastián-Pérez, Víctor; Li, Lingling; Geiger, Larissa; González, Silvia; Campillo, Nuria E.  ; Gil, Carmen  ; Morales, Aixa V. ; Pérez, Daniel I.; Martínez, Ana  artículo
openAccessTesis_Josefa_Zaldivar_Diez de Bonilla_CEU.pdf.jpg2018LRRK2 inhibitors as effective drugs for the treatment of neurodegenerative diseasesZaldívar-Díez, Josefatesis doctoral
openAccess13024_2018_Article_251.pdf.jpg16-Apr-2018Modulation of GSK-3 provides cellular and functional neuroprotection in the rd10 mouse model of retinitis pigmentosaSánchez-Cruz, Alonso; Villarejo-Zori, Beatriz ; Marchena, Miguel; Zaldívar-Díez, Josefa; Palomo, Valle  ; Gil, Carmen  ; Lizasoain, Ignacio; de la Villa, P.; Martínez, Ana  ; De la Rosa, Enrique J.  ; Hernández-Sánchez, Catalina  artículo
openAccessJ.Enz. Inhibit. Med. Chem. 2017.pdf.jpg23-Jan-2017Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosaMarchena, Miguel; Villarejo-Zori, Beatriz ; Zaldívar-Díez, Josefa; Palomo, Valle  ; Gil, Carmen  ; Hernández-Sánchez, Catalina  ; Martínez, Ana  ; De la Rosa, Enrique J.  artículo
closedAccessaccesoRestringido.pdf.jpg2018Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation InhibitorsGandini, A.; Bartolini, M.; Tedesco, D.; Martínez-González, Loreto ; Roca, Carlos; Campillo, Nuria E.  ; Zaldívar-Díez, Josefa; Pérez, Concepción; Zuccheri, G.; Miti, A.; Feoli, A.; Castellano, S.; Petralla, S.; Monti, B.; Rossi, M.; Moda, F.; Legname, G.; Martínez, Ana; Bolognesi, Maria Lauraartículo